The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non‐small cell lung cancer ( ICBP SurvMark ‐2 project)-Reference-Cited by-同舟云学术

The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non‐small cell lung cancer ( ICBP SurvMark ‐2 project)

Published:2021-05-20 Issue:5 Volume:149 Page:1013-1020
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Morgan Eileen¹^ORCID,Arnold Melina¹^ORCID,Rutherford Mark J.²,Bardot Aude¹,Ferlay Jacques¹^ORCID,De Prithwish³,Engholm Gerda⁴,Jackson Christopher⁵,Little Alana⁶,Saint‐Jacques Nathalie⁷,Walsh Paul⁸,Woods Ryan R.⁹,O'Connell Dianne L.¹⁰,Bray Freddie¹^ORCID,Parkin D. Max¹¹,Soerjomataram Isabelle¹

Affiliation:

1. Cancer Surveillance Branch International Agency for Research on Cancer Lyon France

2. Department of Health Sciences University of Leicester Leicester UK

3. Analytics and Informatics Cancer Care Ontario Toronto Ontario Canada

4. Danish Cancer Society Copenhagen Denmark

5. Cancer Society of New Zealand Wellington New Zealand

6. Cancer Institute NSW Alexandria New South Wales Australia

7. Nova Scotia Health Authority Cancer Care Program, Registry & Analytics Halifax Nova Scotia Canada

8. National Cancer Registry Ireland, Cork Airport Business Park Cork Ireland

9. BC Cancer Vancouver British Columbia Canada

10. Cancer Research Division Cancer Council NSW Sydney New South Wales Australia

11. Nuffield Department of Population Health University of Oxford Oxford UK